Systematic Assessment of Vascular Risk
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00378040 |
Recruitment Status
:
Completed
First Posted
: September 19, 2006
Last Update Posted
: May 16, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
It is hypothesized that patients with vascular disease are undertreated for modifiable risk factors, leading to increased morbidity and mortality in this population.
The objective of this study is to develop a comprehensive database that will demonstrate the current adequacy of risk factor management in this high risk population, and that will provide needed guidance for future treatment options.
Condition or disease |
---|
Peripheral Vascular Disease |
Study Type : | Observational |
Actual Enrollment : | 800 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Toronto Vascular Disease Risk Factor Assessment Program: Systematic Assessment of Vascular Risk |
Study Start Date : | June 2004 |
Actual Primary Completion Date : | December 2006 |
Actual Study Completion Date : | December 2015 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 30 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
All patients who attend the Vascular Surgery Clinic at Toronto General Hospital, St. Michael's Hospital, and St. Joseph's Health Centre who have PAD, cerebrovascular disease (CBVD), or aneurysms will be eligible for this study. Patients who are currently enrolled in other clinical studies are eligible for this study; however proper adherence to the other study will take precedence over of the current proposal.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00378040
Canada, Ontario | |
Toronto General Hospital | |
Toronto, Ontario, Canada, M5G 2C4 |
Principal Investigator: | Thomas Lindsay, M.D | Toronto General Hospital, University Health Network |
Responsible Party: | Thomas Lindsay, Professor of Surgery, University Health Network, Toronto |
ClinicalTrials.gov Identifier: | NCT00378040 History of Changes |
Other Study ID Numbers: |
01-541S |
First Posted: | September 19, 2006 Key Record Dates |
Last Update Posted: | May 16, 2016 |
Last Verified: | May 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | See JAMA Surgery 2016 epublished First Author Dr M Hussain |
Additional relevant MeSH terms:
Vascular Diseases Peripheral Vascular Diseases Peripheral Arterial Disease Cardiovascular Diseases |
Atherosclerosis Arteriosclerosis Arterial Occlusive Diseases |